Two Popular Altcoins Announce Partnership for New Blockchain Network: Key Developments for Coin Name (Symbol)

INJ

INJ/USDT

$3.218
-1.08%
24h Volume

$38,685,090.42

24h H/L

$3.362 / $3.20

Change: $0.1620 (5.06%)

Funding Rate

-0.0059%

Shorts pay

Data provided by COINOTAG DATALive data
INJ
INJ
Daily

$3.254

-0.91%

Volume (24h): -

Resistance Levels
Resistance 3$5.0492
Resistance 2$3.7588
Resistance 1$3.3634
Price$3.254
Support 1$3.2445
Support 2$2.981
Support 3$2.65
Pivot (PP):$3.249
Trend:Downtrend
RSI (14):31.4
(04:22 AM UTC)
2 min read

Contents

988 views
0 comments
  • Injective (INJ), a Layer 1 blockchain, has partnered with Arbitrum (ARB) for a critical development.
  • Injective is rolling up its sleeves to launch a Layer-3 (L3) blockchain on the Arbitrum network.
  • Eric Chen, co-founder of Injective Labs, stated that the product to be offered will provide significant benefits to the ecosystem by enabling the transfer of liquidity and assets across multiple blockchains.

Injective partners with Arbitrum to launch a Layer-3 blockchain, aiming to enable cross-chain asset and liquidity transfer, bridging the gap between Ethereum, Cosmos, and other widely adopted L1s.

Injective Partners with Arbitrum for Layer-3 Blockchain Launch

Injective, a Layer 1 blockchain, has announced a partnership with Arbitrum for a significant development. The team at Injective has revealed plans to launch a Layer-3 (L3) blockchain on the Arbitrum network, aiming to create a fast and low-cost network.

Using Arbitrum’s Technology for Cross-Chain Asset and Liquidity Transfer

The “inEVM”, which will connect Ethereum, Cosmos, and Solana networks and assist in cross-chain asset and liquidity transfer, will also allow the creation of customizable blockchains with Arbitrum’s technology. This integration goes beyond just creating blockchain networks or infrastructure. It applies the fundamental principle of interoperability by bridging the gap between Ethereum, Cosmos, and other widely adopted L1s, truly unifying cross-chain assets and liquidity across ecosystems.

Significant Benefits to the Ecosystem

Eric Chen, the co-founder of Injective Labs, commented on the matter, stating that the product to be offered will provide significant benefits to the ecosystem. By enabling the transfer of liquidity and assets across multiple blockchains, it will enhance the interoperability and efficiency of transactions across these networks.

Conclusion

The partnership between Injective and Arbitrum signifies a significant step towards enhancing cross-chain interoperability. While no specific date has been shared for when the L3 project will be implemented, the development is eagerly awaited by the crypto community.

JM

James Mitchell

COINOTAG author

View all posts

Comments

Comments